UPDATE: Lilly shares tumble on earnings report that falls short of Wall Street expectations
| John Russell and Associated Press
The Indianapolis-based drugmaker missed expectations on sales of two popular drugs, diabetes treatment Mounjaro and weight-loss treatment Zepbound, which it attributed to inventory decreases in the wholesaler channel.